Patient-Reported Outcomes of Nirmatrelvir Treatment for High-Risk, Nonhospitalized Adults With Symptomatic COVID-19
Authors
- Wajeeha Ansari (ORCID: https://orcid.org/0000-0002-1910-5836)
- Heidi Leister‐Tebbe
- Amie Scott (ORCID: https://orcid.org/0000-0002-1488-2687)
- Ashley S. Cha-Silva (ORCID: https://orcid.org/0000-0002-8484-6251)
- Jinma Ren (ORCID: https://orcid.org/0000-0002-4616-476X)
- Henriette Coetzer (ORCID: https://orcid.org/0009-0009-7093-9279)
- Kelly A. Gebo (ORCID: https://orcid.org/0000-0003-4010-398X)
- Joseph C. Cappelleri (ORCID: https://orcid.org/0000-0001-9586-0748)
Institutions
- Johns Hopkins University (US)
- Pfizer (United States) (US)
- Johns Hopkins Medicine (US)
- Blue Cross Blue Shield Association (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-07-30
- DOI
- https://doi.org/10.1093/ofid/ofaf449
- Citations
- 3
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 4.17